Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Laryngeal Neoplasms × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 8 Brain Neoplasms 5 Neoplasm Metastasis 3 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adamantinoma 1

Interventions

Cetuximab 6 Cisplatin 5 Radiotherapy, Intensity-Modulated 4 pembrolizumab 2 durvalumab 2 Fluorouracil 2 Docetaxel 2 Celecoxib 2 Carboplatin 2 Bupropion 2 130-nm albumin-bound paclitaxel 2 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1 Radiotherapy 1 Radiation 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 Immunoglobulin G 1 Hydroxyurea 1 Gene Expression Profiling 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Erlotinib Hydrochloride 1 Early Intervention, Educational 1 Drug Therapy 1 Disulfides 1 Dihematoporphyrin Ether 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡